A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Tumour-infiltrating lymphocytes in oropharyngeal cancer: a validation study according to the criteria of the International Immuno-Oncology Biomarker Working Group
Tekijät: Almangush Alhadi, Jouhi Lauri, Atula Timo, Haglund Caj, Mäkitie Antti A, Hagström Jaana, Leivo Ilmo
Kustantaja: SPRINGERNATURE
Julkaisuvuosi: 2022
Journal: British Journal of Cancer
Tietokannassa oleva lehden nimi: BRITISH JOURNAL OF CANCER
Lehden akronyymi: BRIT J CANCER
Vuosikerta: 126
Numero: 11
Aloitussivu: 1589
Lopetussivu: 1594
Sivujen määrä: 6
ISSN: 0007-0920
eISSN: 1532-1827
DOI: https://doi.org/10.1038/s41416-022-01708-7
Verkko-osoite: https://www.nature.com/articles/s41416-022-01708-7
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/175821171
Background
The evaluation of immune response can aid in prediction of cancer behaviour. Here, we assessed the prognostic significance of tumour-infiltrating lymphocytes (TILs) in oropharyngeal squamous cell carcinoma (OPSCC).
Methods
A total of 182 patients treated for OPSCC were included in this study. Assessment of TILs was conducted on tumour sections stained with standard haematoxylin and eosin (HE) staining. We used the scoring criteria proposed by the International Immuno-Oncology Biomarker Working Group.
Results
The multivariable analysis showed that TILs associated with disease-specific survival with a hazard ratio (HR) of 2.13 (95% CI 1.14–3.96; P = 0.017). Similarly, TILs associated significantly with overall survival with HR of 1.87 (95% CI 1.11–3.13; P = 0.018). In a sub-analysis of HPV-positive and HPV-negative cases separately, TILs showed a significant prognostic value in both groups (P < 0.05).
Conclusion
The evaluation of TILs as proposed by the International Immuno-Oncology Biomarker Working Group is a simple and promising method in prediction of survival of OPSCC. It is easily applicable and after further validation can be implemented in the routine pathological report as a basic immune parameter.
Ladattava julkaisu This is an electronic reprint of the original article. |